Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.47 |
| ▸ | AGXT | P21549 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | RELA | Q04206 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19897083 | 0.93 | CYP1A2 (0.45) | CYP1A2CYP2A6CA1CA2CA9 | |
| SCHEMBL14876962 | 0.91 | CYP1A2 (0.39) | CYP1A2CYP2A6CA1CA2CA9 | |
| SCHEMBL8763499 | 0.91 | CBFB (0.39) | CYP1A2CYP2A6CA1CA2CA9 | |
| SCHEMBL28764686 | 0.81 | CYP1A2 (0.57) | CYP1A2CYP2A6KDM4ERAB9APTGS1 | |
| SCHEMBL1587526 | 0.80 | CYP2A6 (0.56) | CYP1A2CYP2A6CA1CA9KDM4E | |
| SCHEMBL14585876 | 0.79 | CYP1A2 (0.37) | CYP1A2CYP2A6CA1CA2CA9 | |
| SCHEMBL11511855 | 0.78 | NCEH1 (0.47) | CYP1A2CYP2A6TDP1MEN1MAPT | |
| SCHEMBL12457069 | 0.78 | ALDH1A1 (0.46) | CA1CA2CA9TDP1MEN1 | |
| SCHEMBL3167621 | 0.78 | CYP1A2 (0.46) | CYP1A2TDP1MEN1MAPTKMT2A | |
| SCHEMBL4570685 | 0.78 | CYP2A6 (0.54) | CYP1A2CYP2A6CA9TDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2062 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | claimed |
| EP-4482306-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-01 | — | — | EP | claimed |
| EP-3816153-B1 | HETEROCYCLIC COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICALS CO (JP) | 2023-10-18 | — | — | EP | claimed |
| WO-2023192424-A1 | VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-05 | — | — | WO | claimed |
| CN-112203699-B | Method for inhibiting odor generation | 花王株式会社 | 2022-11-29 | — | — | CN | claimed |
| CN-112203699-A | Method for inhibiting odor generation | 花王株式会社 | 2021-01-08 | — | — | CN | claimed |
| CN-102558550-B | Heat-resistant polyamide resin matrix material and preparation method thereof | Daiichi Woolen Co.,Ltd. (KR) | 2015-09-30 | — | — | CN | claimed |
| CN-102942552-B | 3,11-disubstituted-14-aryl-14H-dibenzo[a,j]xanthene derivatives, preparation methods and uses thereof | UNIV HARBIN MEDICAL | 2015-06-24 | — | — | CN | claimed |
| CN-102627853-B | High-temperature elastomer nylon and preparation method thereof | KINGFA SCIENCE & TECHNOLOGY CO | 2014-01-08 | — | — | CN | claimed |
| CN-102942552-A | 3,11-disubstituted-14-aryl-14H-dibenzo[a,j]xanthene derivatives, preparation methods and uses thereof | UNIV HARBIN MEDICAL | 2013-02-27 | — | — | CN | claimed |
| US-5942365-A | CHARGE ADJUVANT OF ALUMINUM SALT OF AN ACID; SMEARING, LOSS OF RESOLUTION AND LOSS OF DENSITY ELIMINATED OR MINIMIZED | XEROX CORPORATION (US) | 1999-08-24 | — | — | US | claimed |
| US-5830897-A | AIDS THERAPY | G. D. SEARLE & CO. (US) | 1998-11-03 | — | — | US | claimed |
| EP-0656887-B1 | HYDROXYETHYLAMINO SULFONAMIDES USEFUL AS RETROVIRAL PROTEASE INHIBITORS | SEARLE & CO (US) | 1998-10-28 | — | — | EP | claimed |
| EP-0666842-B1 | HYDROXYETHYLAMINO SULFAMIC ACID DERIVATIVES USEFUL AS RETROVIRAL PROTEASE INHIBITORS | SEARLE & CO (US) | 1998-06-24 | — | — | EP | claimed |
| EP-0666842-A1 | HYDROXYETHYLAMINO SULFAMIC ACID DERIVATIVES USEFUL AS RETROVIRAL PROTEASE INHIBITORS | G.D. SEARLE & CO. (US) | 1995-08-16 | — | — | EP | claimed |
| EP-0656887-A1 | HYDROXYETHYLAMINO SULFONAMIDES USEFUL AS RETROVIRAL PROTEASE INHIBITORS | G.D. SEARLE & CO. (US) | 1995-06-14 | — | — | EP | claimed |
| WO-1994010134-A1 | HYDROXYETHYLAMINO SULFAMIC ACID DERIVATIVES USEFUL AS RETROVIRAL PROTEASE INHIBITORS | G.D. SEARLE & CO. (US) | 1994-05-11 | — | — | WO | claimed |
| WO-1994004492-A1 | HYDROXYETHYLAMINO SULFONAMIDES USEFUL AS RETROVIRAL PROTEASE INHIBITORS | G.D. SEARLE & CO. (US) | 1994-03-03 | — | — | WO | claimed |
| EP-0180188-B1 | A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-04-15 | — | — | EP | claimed |
| US-4057576-A | Process for isolating 2-hydroxynaphthalene carboxylic acids from reaction mixtures of the alkali metal salts of 2-hydroxynaphthalene with carbon dioxide | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-11-08 | — | — | US | claimed |